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Malaria remains one of the greatest burdens to global health, causing nearly 500,000 deaths
in 2014. When manifesting in the lungs, severe malaria causes acute lung injury/acute respi-
ratory distress syndrome (ALI/ARDS). We have previously shown that a proportion of DBA/
2 mice infected with Plasmodium berghei ANKA (PbA) develop ALI/ARDS and that these
mice recapitulate various aspects of the human syndrome, such as pulmonary edema,
hemorrhaging, pleural effusion and hypoxemia. Herein, we investigated the role of neutro-
phils in the pathogenesis of malaria-associated ALI/ARDS. Mice developing ALI/ARDS
showed greater neutrophil accumulation in the lungs compared with mice that did not
develop pulmonary complications. In addition, mice with ALI/ARDS produced more neutro-
phil-attracting chemokines, myeloperoxidase and reactive oxygen species. We also
observed that the parasites Plasmodium falciparum and PbA induced the formation of neu-
trophil extracellular traps (NETs) ex vivo, which were associated with inflammation and tis-
sue injury. The depletion of neutrophils, treatment with AMD3100 (a CXCR4 antagonist),
Pulmozyme (human recombinant DNase) or Sivelestat (inhibitor of neutrophil elastase)
decreased the development of malaria-associated ALI/ARDS and significantly increased
mouse survival. This study implicates neutrophils and NETs in the genesis of experimentally
induced malaria-associated ALI/ARDS and proposes a new therapeutic approach to
improve the prognosis of severe malaria.
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Author Summary
A deeper understanding of the pathogenesis of malaria-associated ALI/ARDS may help in
the development of new therapeutic approaches to improve the prognosis of severe cases
of malaria. Using the Plasmodium berghei ANKA-infection mouse model of ALI/ARDS,
which resembles the human disease in many aspects, this study reports the critical role of
neutrophils in the pathogenesis of this syndrome. Mice developing ALI/ARDS showed
abundant lung-infiltrating neutrophils in association with the increased production of
neutrophil-attracting chemokines, myeloperoxidase and reactive oxygen species. The par-
asites Plasmodium falciparum and P. berghei ANKA both induced the formation of neu-
trophil extracellular traps ex vivo. By targeting neutrophils and neutrophil extracellular
traps with specific drugs, we succeeded in preventing the development of malaria-associ-
ated ALI/ARDS and significantly increased mouse survival.
Introduction
Malaria is one of the most common infectious diseases and is an enormous public-health prob-
lem. In some individuals, a Plasmodium infection results in severe malaria. The main compli-
cations associated with this severe disease are cerebral malaria, metabolic acidosis, severe
anemia, placental malaria, renal and hepatic insufficiency and acute lung injury/acute respira-
tory distress syndrome (ALI/ARDS), which can occur alone or in combination [1,2]. Patients
infected with Plasmodium falciparum, Plasmodium vivax, and Plasmodium knowlesi can
develop ALI or ARDS, with a mortality rate close to 80% [3].
Neutrophils are one of the key cells in the pathophysiology of ALI/ARDS driven by various
conditions [4]. They are recruited to lung tissue where they release reactive oxygen (ROS) and
nitrogen species (RNS), cationic proteins, such as myeloperoxidase (MPO); lipid mediators;
inflammatory cytokines; elastase and matrix metalloproteinases. Although these molecules are
toxic to invading pathogens, they also promote epithelial and endothelial damage [5–8]. The
accumulation of proteinaceous substances [7,9] and the inefficient phagocytosis of apoptotic
neutrophils also promote tissue injury [10]. Post-mortem examinations of the lungs of patients
with malaria-associated ALI/ARDS have shown the presence of pulmonary edema, inflamma-
tory infiltrates and accumulated inflammatory cells, including neutrophils, in the interstitial
and alveolar spaces [11,12]. Moreover, a recent report showed higher neutrophil numbers in
the peripheral blood of patients with severe malaria compared with numbers in uncomplicated
cases in an Indian cohort [13]. Thus, evaluating the contribution of neutrophils to malaria asso-
ciated-ALI/ARDS may help clarify the cellular and molecular mechanisms involved in the path-
ogenesis of this disease, which is essential for the development of new therapeutic approaches.
There are several mouse models of pulmonary pathologies associated with Plasmodium
infections with a wide range of severity [14–18] that can be used to investigate the relevance of
neutrophils in malaria associated-ALI/ARDS. C57BL/6 mice infected with Plasmodium berghei
NK65 showed evidence of damage in their alveolar epithelia, mixed inflammatory infiltrates
containing macrophages, neutrophils and lymphocytes, as well as hemorrhages, severe edema
and, in some cases, the development of hyaline membranes [19], which were also found in
DBA/2 mice infected with P. berghei ANKA (PbA) showing symptoms of ALI/ARDS [18].
However, CD8+ T lymphocytes have been demonstrated to be important in the induction of
ALI/ARDS in C57BL/6 mice infected with P. berghei NK65 [19].
Here, we used a previously reported mouse model in which 30–60% of DBA/2 mice
infected with PbA die as a result of ALI/ARDS symptoms between 7–12 days post-infection
Malaria-Associated ALI/ARDS and Neutrophil Response
PLOS Pathogens | DOI:10.1371/journal.ppat.1006054 December 7, 2016 2 / 24
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors declare no
commercial or other associations that might pose
conflicts of interest.
(dpi) [18,20]. DBA/2 mice suffering from ALI/ARDS show a loss of integrity of the alveolar-cap-
illary barrier, including increased vascular permeability, pulmonary edema, hemorrhaging and
leukocyte infiltration. Moreover, in this mouse model, we are able to identify mice that will likely
die from ALI/ARDS using predictive criteria based on respiratory parameters and the extent of
parasitemia [18]. Our data highlight the important potential of understanding the molecular
mechanisms of malaria-associated ALI/ARDS as a way to identify new therapeutic targets.
Results
Infected red blood cell (iRBC) loads in the lung are associated with the
development of ALI/ARDS in PbA-infected DBA/2 mice
As in our previous study [18,20], a proportion of DBA/2 mice died during the second week of
PbA infection with relatively low parasitemia levels (Fig 1A and 1B). Using enhanced respira-
tory pause (Penh), respiratory frequency (RF) and parasitemia values as predictive criteria, we
have previously shown that these mice develop ALI/ARDS and that the remaining group dies
after developing hyperparasitemia (HP)[18]. Based on these parameters, mice were divided
into two groups on the 7th dpi (S1 Fig). The mice with ALI/ARDS showed a significantly
increased Penh and decreased RF compared with the values in mice developing HP (Fig 1C
and 1D), but both groups presented similar levels of parasitemia on the 7th dpi (Fig 1E).
We verified parasite distribution and adhesion in various organs via bioluminescence anal-
ysis using DBA/2 animals infected with PbA expressing luciferase. Luciferin injections were
made on the 7th dpi, and perfused mice showed parasite loads, especially in the lungs and
spleen. Moreover, mice that developed ALI/ARDS (with hydrothorax) showed more parasites
in their lungs than mice developing HP (Fig 1F).
Neutrophils are involved in the pathogenesis of malaria-associated
ALI/ARDS
To investigate the mechanism responsible for the development of malaria-associated
ALI/ARDS, leukocytes in the lungs and bronchoalveolar lavage fluid (BALF) were analyzed
on the 7th dpi.
Histological sections of lungs from mice with ALI/ARDS revealed an intense inflammatory
infiltrate, along with numerous neutrophils (Fig 2A). Flow cytometry analysis of the inflamma-
tory cells from the lungs showed a significantly greater increase in the Ly6G+CD11b+ neutro-
phil population in mice with ALI/ARDS than in those developing HP (Fig 2B). Accordingly,
the mRNA expression of Ncf2, a neutrophil-specific marker, was upregulated in the lungs of
mice with ALI/ARDS compared with its expression in those developing HP (Fig 2C). Consis-
tent with neutrophil trafficking into the lungs of mice with ALI/ARDS, chemoattractants
known to be produced by macrophages [21] and associated with ALI/ARDS-related injuries
[22], such as the chemokines KC (CXCL-1) and MIP-2 (CXCL-2), were found at higher con-
centrations in sera of mice with ALI/ARDS than in that of mice with HP on both the 3rd and
5th dpi (Fig 2D and 2E).
Additionally, on the 7th dpi, neutrophils from the lungs of mice with ALI/ARDS showed
increased ROS production (DHR+) compared with those from mice developing HP (Fig 2F
and S2 Fig). Likewise, we found increased MPO activity in the lungs (Fig 2G) and BALF (Fig
2H) of mice with ALI/ARDS on the 7th dpi, indicating neutrophil activity within the alveolar
space. In addition, macrophage/monocyte populations were prevalent in the BALF on the 7th
dpi, and they did not differ between the different groups. In contrast, the number of neutro-
phils was significantly higher in mice with ALI/ARDS than in those developing HP (Fig 2I),
Malaria-Associated ALI/ARDS and Neutrophil Response
PLOS Pathogens | DOI:10.1371/journal.ppat.1006054 December 7, 2016 3 / 24
Fig 1. Infected red blood cells (iRBCs) loads in the lung are associated with the development of ALI/ARDS in PbA-
infected DBA/2 mice. (A) Survival curve and (B) parasitemia of DBA/2 mice infected with 106 P. berghei ANKA iRBCs. The gray
frame shows the period between the 7th and 12th days post-infection (dpi) where approximately 60% of the animals died with signs
of ALI/ARDS. (C) Enhanced respiratory pause (Penh) and (D) respiratory frequency (RF), as well as (E) parasitemia were
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and more iRBCs were visualized in the BALF of mice with ALI/ARDS (Fig 2J). All together,
these data indicate that neutrophils are recruited in higher numbers and are more active in
mice with ALI/ARDS than in mice developing HP.
Early depletion of neutrophils protects mice from ALI/ARDS
To investigate the relevance of neutrophils in the development of malaria-associated ALI/
ARDS, DBA/2 mice infected with PbA received a single dose of anti-GR1 IgG antibody (RB6-
8C5) or an isotype control IgG (control group) on the 1st dpi. Consistent with a key role of
neutrophils in the establishment of ALI/ARDS, none of the anti-GR1-treated mice developed
the syndrome, and their survival rate was higher than that of the control group, in which, as
expected, 60% of the mice died with signs of ALI/ARDS between 7 to 12 dpi (Fig 3A). No dif-
ferences in parasitemia were observed between the anti-GR1-treated mice and isotype-con-
trol-treated mice (Fig 3B). Accordingly, on the 7th dpi, the anti-GR1-treated mice presented a
decrease in Penh and an increase in RF compared with values in the isotype-control-treated
mice that developed ALI/ARDS (Fig 3C and 3D).
Severe pulmonary edema and alveolar hemorrhaging were observed in histological lung
sections of the isotype-control-treated mice, while the anti-GR1-treated mice showed only a
thickening of the interstitium on the day of death (Fig 3E). The depletion of neutrophils in the
anti-GR1-treated mice was effective from the 2nd to 7th dpi (1st to 6th day post-antibody treat-
ment) (Fig 3F and 3G). However, on the 9th dpi (8th day post-antibody treatment), the neutro-
phil population in the blood returned to control levels. On the 1st day post-anti-GR1
treatment, a small and transient decrease in blood monocytes was also observed, followed by
an increase in monocytes on the 5th dpi (S3A and S3B Fig). An increase was also observed in
blood lymphocytes from the 2th to 7th dpi (S3C and S3D Fig), which might be a compensatory
mechanism in response to the lack of neutrophils.
Treatment with a CXCR4 antagonist protects mice from ALI/ARDS
The CXCR4/CXCL12 signaling pathway is central to the migration of neutrophils and fibro-
blasts to the lung tissue in response to lung injuries due to different causes [23–26]. Hypothe-
sizing that the CXCR4/CXCL12 axis would be important in this model of malaria-associated
ALI/ARDS, we investigated its role. We used a plerixafor, AMD3100, which is a non-peptide
bicyclam derivative compound that antagonizes CXCR4 and inhibits its binding to CXCL12
and thus its function [27,28], preventing neutrophil accumulation. DBA/2 mice infected with
PbA were treated with four doses of AMD3100, on the 1st, 3th, 5th and 7th dpi. Surprisingly,
between the 7th and 12th dpi, 60% of untreated mice died with signs of ALI/ARDS, whereas
only 10% of the mice treated with AMD3100 developed the disease, and 90% survived until the
end of the experiment (Fig 4A), despite there being no differences in parasitemia between the
groups (Fig 4B). The untreated mice that developed ALI/ARDS presented pleural effusion,
hemorrhaging and intense inflammatory infiltration on the day of death (Fig 4C); however,
AMD3100 treated-mice showed only minimal thickening of the alveolar septa on the day of
death, indicating that blocking the action of CXCR4 with AMD3100 was effective in reducing
measured on the 7th dpi. Data are representative of five independent experiments and are expressed as the mean ± SEM (Mann-
Whitney test or Kruskal-Wallis test; n = 10–12 mice/experiment; *p<0.015 and **p<0.007). (F) Bioluminescence of DBA/2 mice
infected with Plasmodium berghei ANKA-expressing luciferase (PbA-L) on the 7th day post-infection after the administration of
luciferin. (T-test; n = 3 mice/group) mean ± SEM; *p <0.05). (G) ALI/ARDS-developing (hydrothorax) and HP-developing mouse
(without hydrothorax) perfused or not with 1x PBS and isolated organs (1: brain; 2: heart; 3: lung; 4: kidney; 5: liver; 6: spleen).
Images were captured and analyzed using an IVIS Spectrum instrument. The dashed line represents the mean value for the NI
mice. NI: non-infected; ALI/ARDS: acute lung injury/acute respiratory distress syndrome; HP: hyperparasitemia.
doi:10.1371/journal.ppat.1006054.g001
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Fig 2. Neutrophils are involved in the pathogenesis of malaria-associated ALI/ARDS. DBA mice were infected with 106
P. berghei ANKA-iRBCs. (A) Representative lung photomicrograph (630x, scale bar 10 μm) of tissue from a mouse with ALI/
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the pathological responses associated with the decrease in neutrophils in the lungs of
AMD3100-treated mice, on the 7th dpi (Fig 4D). In addition, bone marrow cellular density
was higher in the AMD3100-treated mice than in the untreated mice on the day of death, indi-
cating greater cellular retention (S4 Fig). The respiratory parameters on the 7th dpi were also
altered: Penh was decreased, and RF was increased in the AMD3100-treated mice compared
with values in the control mice (Fig 4E and 4F).
Plasmodium-induced neutrophil extracellular trap (NET) formation
contributes to the pathogenesis of malaria-associated ALI/ARDS
Our previous results show increases in neutrophil recruitment and in ROS and MPO produc-
tion in the lungs of mice developing ALI/ARDS, all of which are favorable conditions for NET
formation. The generation of ROS and the release of MPO are, respectively, the initial and
later steps of NET generation [27,29,30]. Hypothesizing that NETs contribute to the develop-
ment of malaria-associated ALI/ARDS, we investigated if P. falciparum and PbA could induce
NETosis ex vivo. Indeed, we observed NET formation following the stimulation of human neu-
trophils with P. falciparum-iRBCs (Fig 5A) and mouse neutrophils with PbA-iRBCs and an
iRBC lysate (Fig 5B). In addition, we quantified NETosis ex vivo in mouse neutrophils using
Sytox Green over 60, 120, and 180 minutes (Fig 6). The neutrophils stimulated with iRBCs
showed a significant increase in fluorescence intensity from 120 minutes (confirming more
NETosis) when compared with RBC-stimulated neutrophils (Fig 6B).
In vivo, we identified NETs in the lungs of PbA-infected mice on the day of death (Fig 7A)
and also in the peripheral blood of PbA-infected mice (S5 Fig), suggesting that this mechanism
is involved in malaria-associated ALI/ARDS. To ascertain the effect of NETs on the pathogene-
sis of ALI/ARDS, we used Pulmozyme (Roche, USA), a DNA disrupting drug, to treat DBA/2
mice on the 3th and 6th dpi. We observed that while 40–60% of the untreated mice died with
signs of ALI/ARDS, fewer than 20% of the mice treated with Pulmozyme showed lung compli-
cations on the day of death, and none died of ALI/ARDS until the 20th dpi (Fig 7B). We found
no differences in parasitemia associated with or without the drug treatment (Fig 7C), but Pul-
mozyme-treated mice had decreased Penh and increased RF values on the 7th dpi. (Fig 7D and
7E). In addition, we treated the mice with Sivelestat, an inhibitor of neutrophil elastase, and
observed an increase in survival, with just 15% of mice showing pulmonary involvement (com-
pared with the 75% of untreated mice that died of ALI/ARDS) (Fig 7F). There was no differ-
ence in parasitemia between groups (Fig 7G): however, Sivelestat-treated mice showed
decreased Penh and increased RF values compared with untreated mice on the 7th dpi (Fig 7H
and 7I). As with Pulmozyme treated mice, elastase inhibitor-treated mice did not show histo-
logical signals of ALI/ARDS, instead they showed only minimal interstitial thickening, whereas
mice in the control group died of ALI/ARDS and presented a phenotype characterized by
edema, hemorrhaging, and a high influx of inflammatory cells (Fig 7J).
ARDS stained with HE, highlighting the inflammatory infiltrate, especially of neutrophils (arrows and insert) on the day of death
(11th day post-infection (dpi). (B) Neutrophil number (Ly6G+CD11b+) and (C) Ncf2 gene expression in the lungs. (D) KC
(CXCL-1) and (E) MIP-2 (CXCL-2) in the sera of mice with ALI/ARDS (red) and HP (black) on the 3rd and 5th dpi. Number of
neutrophils (Ly6G+CD11b+) producing (F) reactive oxygen species (DHR+) in the lungs or producing myeloperoxidase (MPO)
in the (G) lungs and (H) bronchoalveolar lavage fluid (BALF) of mice with ALI/ARDS compared with those from mice with
HP. (I e J) Leukocytes in the BALF of mice. Arrowheads indicate neutrophils (400x, scale bar 25 μm). Data for three grouped
experiments are expressed as the mean ±SEM. The data from figures B, C, F, G, H, I and J were collected on the 7th dpi. (Mann-
Whitney test and Kruskal-Wallis test; (n = 5); ALI/ARDS: n = 12–20, HP: n = 10–15; * p <0.05, ** p <0.01 and *** p <0.001). The
dashed horizontal line represents the mean value for the NI mice. M/M: monocytes and macrophages, L: lymphocytes and N:
neutrophils. NI: non-infected; ALI/ARDS: acute lung injury/acute respiratory distress syndrome; HP: hyperparasitemia.
doi:10.1371/journal.ppat.1006054.g002
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All together, these results show that preventing NET formation using Pulmozyme or the
inhibitor elastase Sivelestat improved respiratory parameters and no signs of ALI/ARDS, such
as edema, hemorrhaging, and the high influx of inflammatory cells.
Neutrophil interactions in malaria-associated ALI/ARDS
In Fig 8, we summarize the events leading to lung tissue damage associated with ALI/ARDS.
During PbA infections, DBA/2 mice that develop ALI/ARDS show a higher number of neutro-
phils migrating into the lung tissue. Neutrophils from the microcirculation enter the intersti-
tium and alveoli where they produce ROS, release enzymes (MPO) and form NETs, resulting
in damage to epithelial tissue in the lungs associated with cytokine release, the death of endo-
thelial and epithelial cells and increased vascular permeability and, consequently, edema. The
course of the infection leads to hypoxemia and respiratory failure, which suggests that the use
of drugs to inhibit the chemotaxis of neutrophils and the production of their inflammatory
mediators may have a positive effect.
Discussion
This study demonstrates the pivotal role of neutrophils in the establishment of malaria-associ-
ated ALI/ARDS. Using the PbA-infected DBA/2 mouse model previously established in our
laboratory [18], we have shown that Penh and RF values on the 7th dpi can predict whether
mice will die earlier with ALI/ARDS or later with HP. Here, we show that during the develop-
ment of ALI/ARDS, but not HP, neutrophils migrate and accumulate in lung inflammatory
infiltrates, where they actively produce ROS and MPO, which are known to contribute to lung
pathogenesis. The depletion of neutrophils, inhibition of neutrophil trafficking or inhibition of
NET formation prior to the appearance of ALI/ARDS symptoms improves respiratory param-
eters, histopathological findings and mouse survival, thus confirming the dependency on neu-
trophils for establishing this syndrome.
Our data indicate that lung pathologies in this model of malaria-associated ALI/ARDS are
orchestrated by neutrophils and that CXCR4/CXCL12 are the receptor/chemokine responsible
for their trafficking. CXCL12 is mainly produced by bone marrow stromal cells, including vas-
cular endothelial cells, and this receptor/chemokine complex has been associated with the traf-
ficking of immune cells in other infectious diseases [23,30–32] and has been shown to
modulate neutrophils with only minimal effects on the monocyte compartment [31]. Various
diseases, especially those involving the lungs, are improved by treatments that block CXCR4
[23,33,34]. A specific CXCR4 antagonist has been shown to inhibit neutrophil accumulation
into air spaces and attenuate the increase in lung permeability during LPS-induced lung injury
[23]. Furthermore, it has been demonstrated that AMD310 releases neutrophils from the mar-
ginal pool in the lung into the blood but does not change the output of bone marrow neutro-
phils [35], as shown in our findings.
We show here that, once in the lungs, neutrophils in mice developing ALI/ARDS produce
ROS and MPO, whereas those in mice developing HP do not. In other models of lung injury,
Fig 3. Early depletion of neutrophils protects DBA/2 mice from ALI/ARDS. (A) Survival and (B) parasitemia curves in P. berghei ANKA-
infected mice treated with 0.2 mg/kg of anti-GR1 or IgG antibodies (control group) on the 1st day post-infection (dpi). Respiratory parameters
(C) enhanced pause (Penh) and (D) respiratory frequency on the 7th dpi. (E) Photomicrographs of lung tissue on the day of death from non-
infected mice, control mice (8th dpi) and anti-GR1 treated mice (18th dpi) (400x, scale bar 25 μm). Number/frequency of neutrophils in the
blood from infected control (black) and anti-GR1-treated (gray) mice measured via (F) flow cytometry and (G) an analysis of the blood
smears. Data are representative of three independent experiments and are expressed as the mean ± SEM (A, log-rank test and Wilcoxon-
Gehan-Breslow test, p<0.05; Mann Whitey-test, * p <0.05, ** p <0.01 and *** p <0.001; n = 15–20 mice/experiment). The dashed line
represents the mean value for the non-infected mice (NI).
doi:10.1371/journal.ppat.1006054.g003
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Fig 4. CXCR4 antagonist treatment protects DBA/2 mice from ALI/ARDS. (A) Survival and (B) parasitemia curves in
P. berghei ANKA-infected mice treated with 5 mg/kg of AMD3100 or DMSO + saline solution (control group) on the 1st, 3rd,
5th and 7th days post-infection (dpi). (C) Lung tissues from untreated mice (CTR) (died on the 9th dpi with ALI/ARDS) and
AMD3100-treated mice (died on the 21st dpi due to hyperparasitemia) (400x, scale bar 25 μm). (D) Number of neutrophils in
the lungs, measured via flow cytometry, from infected AMD3100-treated mice and control mice (CTR). (E) Enhanced
respiratory pause (Penh) and (F) respiratory frequency (RF) data for these mice. Data are representative of three independent
experiments and are expressed as the mean ±SEM. The data from (D) to (F) were collected on the 7th dpi. (A, log-rank test
and Wilcoxon-Gehan-Breslow test, p<0.05; Mann Whitey-test, *p<0.05, ** p<0.01 and *** p<0.001; n = 10–15 mice/
experiment). The dashed line represents the mean value for the non-infected mice (NI).
doi:10.1371/journal.ppat.1006054.g004
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it has been shown that treatment with immunoregulatory drugs decreases the production of
ROS and MPO [36,37]. We hypothesize that the same effect would occur in PbA-induced ALI/
ARDS, predicting that without ROS and MPO, NET formation would not occur; however, this
remains to be demonstrated. In a model of ALI/ARDS associated with E. coli, it has been
observed that sick animals show an increase in neutrophils in the lungs, a decrease in neutro-
phil apoptosis and an increase in the production of ROS and MPO by neutrophils. Moreover,
animals treated with resolvin E1, a lipid mediator that reduces inflammation, showed an
increase in apoptosis and a decrease in ROS, MPO, and IL-6 production by neutrophils, pro-
moting disease resolution [38].
Previous studies showed that parasites such as Eimeiria spp, Toxoplasma gondii, Besnoitia
besnoiti, and Leishmania amazonensis, among others, are able to stimulate neutrophils to form
NETs [39–43], and fungal infection of Candida albicans hyphae and Aspergillus fumigatus
induce NET formation in the lung of mice [44]. In addition, the presence of circulating NETs
in the blood has been reported in children with uncomplicated P. falciparum malaria [45].
Here, NET formation was implicated for the first time in the development of malaria-associ-
ated ALI/ARDS. We observed NET formation ex vivo by stimulating human and mouse neu-
trophils with P. falciparum and PbA iRBCs, respectively. Most importantly, we showed that
the inhibition of NET formation by treating mice with recombinant human DNase (rhDNase,
Pulmozyme) or elastase inhibitor (Sivelestat) greatly reduced lung pathologies and increased
Fig 5. Plasmodium falciparum and Plasmodium berghei induce neutrophil extracellular trap (NET) formation. (A)
Immunofluorescence of a human neutrophil culture stimulated with PMA (positive control) and P. falciparum (iRBCs) stained for
neutrophil elastase (green), histone (red) and DNA (blue). Overlapping colors indicate filamentous structures (NETs) (400x, scale
bar 25 μm). (B) Immunofluorescence of a DBA/2 mice neutrophil culture stimulated with PMA (positive control), red blood cells
(RBCs), P. berghei lysate and P. berghei ANKA (iRBCs) stained for myeloperoxidase (green), histone (red), and DNA (blue) with
overlapping pictures (1000x, scale bar 20 μm).
doi:10.1371/journal.ppat.1006054.g005
Fig 6. Plasmodium berghei-iRBCs promote more NETs than RBCs in mouse neutrophils. (A)
Immunofluorescence of non-stimulated (NS) DBA/2 mouse neutrophils and of neutrophils stimulated with PMA
[positive control (PC)], red blood cells (RBCs), and P. berghei ANKA (iRBCs) stained with Sytox Green (630x, scale
bar 20 μm). (B) Quantification of extracellular DNA (NETs) using Sytox Green based on units of arbitrary
fluorescence (UAF). Measurements were performed after 60, 120 and 180 minutes of stimulation. The data are
representative of three independent experiments with mean ± SEM (Kruskal-Wallis test where *** p <0.001,
between iRBC and RBC).
doi:10.1371/journal.ppat.1006054.g006
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Fig 7. Recombinant human DNase 1 (Pulmozyme) and an elastase inhibitor (Sivelestat) improve outcomes of malaria-associated
ALI/ARDS. (A) Lung sections of DBA/2 mice infected with 106 P. berghei ANKA-iRBCs on the day of death (9th dpi) were stained for histone
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mouse survival. Accordingly, it has been shown that rhDNase treatment prevents NET forma-
tion in the alveoli and, as a consequence, improves pulmonary function and diminishes hyp-
oxia in a transfusion-related model of acute lung injury [29]. It also decreases neutrophil
accumulation and activation in cystic fibrosis patients [27]. The neutrophil elastase is a serine
protease present in azurophilic granules that contributes to tissue injury when released during
the inflammatory process [46,47]. However, elastase inhibitor treatment in patients with SIRS
has been shown to improve the symptoms of this disease, decreasing ventilation times without
adverse effects during and after treatment [8,46,48].
For more than 10 years, drugs such as Pulmozyme, Sivelestat, and AMD3100 have been
used in patients as adjuvant treatments of various diseases [8,46,48–52], and they are commer-
cially available. However, the main criticism of studies conducted in Japan with elastase inhibi-
tors is that they did not include patients with severe lung disease such as ALI/ARDS [53,54].
(red), myeloperoxidase (MPO) (green), and DNA (blue). Overlapping colors indicate cloud-like structures. White arrowheads show selected
cells forming NETs (400x, scale bar 25 μm). (B) Survival, (C) parasitemia, (D) enhanced respiratory pause (Penh) and (E) respiratory
frequency (RF) on the 7th days post-infection (dpi) in P. berghei ANKA-infected mice treated with Pulmozyme (50 μg/mouse) or saline solution
(control group) on the 3rd and 6th dpi. Data are representative of three independent experiments. (F) Survival, (G) parasitemia, (H) enhanced
respiratory pause (Penh) and (I) respiratory frequency (RF) on the 7th dpi in P. berghei ANKA-infected mice treated with elastase inhibitor (30
mg/kg) or saline solution (control group) on the 3rd and 6th dpi. Data are representative of one experiment. (J) Lung tissue on the day of death
from representative control mice (died on the 10th dpi with ALI/ARDS), Pulmozyme-treated mice (died on the 20th dpi), and Sivelestat-treated
mice (died on the 20th dpi) stained with HE (400x, scale bar 25 μm). Data are expressed as the mean ± SEM (C, log-rank test and Wilcoxon-
Gehan-Breslow, p<0.05; Mann Whitey-test, *** p <0.001; n = 10–15 mice/experiment). The dashed line represents the mean value of non-
infected mice (NI).
doi:10.1371/journal.ppat.1006054.g007
Fig 8. Neutrophil interactions in malaria-associated ALI/ARDS. Following P. berghei ANKA infection in
DBA/2 mice, neutrophils promote the pathogenesis of ALI/ARDS. In particular, the release of myeloperoxidase
and reactive species of oxygen and the formation of neutrophil extracellular traps determines the cause of
death of these mice.
doi:10.1371/journal.ppat.1006054.g008
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Therefore, our data indicate that Pulmozyme, AMD3100 and elastase inhibitors could be
considered as adjuvant treatments to prevent malaria-associated ALI/ARDS in patients.
High serum levels of KC and MIP-2, selective chemoattractants for neutrophils, lead to the
accumulation of these cells in the lungs. Moreover, various inflammatory factors, such as C5a,
PAF, IL-8 and TNF-α, induce neutrophil activation [55]. However, it remains unclear what
promotes the activation of neutrophils in the lungs of mice developing ALI/ARDS and not in
those of mice developing HP. It is possible that the sequestration of iRBCs in the lungs pro-
motes the release of different immune mediators from lung endothelial and epithelial cells.
One such cytokine, IL-33, has recently been associated with pulmonary edema in severe
malaria cases in Southeast Asian patients and was found to be positively correlated with neu-
trophils and activated monocytes [56]. It will be of interest to use the mouse model of malaria-
associated ALI/ARDS to investigate if IL-33 indeed has a role in PbA-induced lung pathologies
and to examine what the molecular and immune mechanisms underlying the changes may be
and how they can be prevented or controlled. Studies investigating allergies and auto-immu-
nity in the context of lung mucosa [56,57] are likely to be informative in showing how Plasmo-
dium infections can develop into lung pathologies and in helping to clarifying the host-
pathogen interactions that mediate these changes.
Our experimental model offers a unique view of the regulation and plasticity of the immune
system in response to PbA infections, with an emphasis on lung pathology that may help
understanding malaria-associated ALI/ARDS and contribute to early diagnoses and effective




Ten to twelve DBA/2 mice per group (survival group and euthanatized groups) were infected
with 106 Plasmodium berghei ANKA (PbA)-infected red blood cells (iRBCs) at the same time.
In the survival group, mice showing pleural effusion or red and congested lungs at necropsy,
the cause of death was designated as ALI/ARDS. For mice without pleural effusion that died
after 13 days post-infection (dpi) with pale lungs and high levels of parasitemia, the cause of
death was designated as hyperparasitemia (HP). By using respiratory patterns (enhanced
pause and respiratory frequency) and the degree of parasitemia as predictive criteria, we estab-
lished cut-off values using receiver operating characteristic (ROC) curves for these parameters
measured on the 7th dpi based on data from mice whose cause of death was known (survival
group). Afterwards, we retrospectively diagnosed the euthanized mice as suffering from ALI/
ARDS or HP by comparing their respiratory patterns and parasitemia measured on the 7th dpi
with the cut-off values from the survival group at the end of each experiment (20th dpi), as pre-
viously described [18] and as illustrated in S1 Fig. Samples (lung tissue, blood and bronchoal-
veolar lavage fluid (BALF)) were collected from mice on the 7th dpi from the euthanized
group.
To measure chemokines, samples were collected on the 3rd and 5th dpi from the survival
group, and lung tissues for histological analyses used to verify the cause of death were collected
on the day of death.
Ethics statement
All experiments were performed in accordance with the ethical guidelines for experiments
with mice, and the protocols were approved by the Animal Health Committee of the Biomedi-
cal Sciences Institute of the University of São Paulo (CEUA n˚ 003, page 98, book 2), of the
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Tropical Medicine Institute of the University of São Paulo (n˚ CPE-IMT 2011/123) and of the
Federal University of São Paulo (CEP 1712/09). The guidelines for animal use and care were
based on the standards established by The Brazilian College of Animal Experimentation
(COBEA). Ethical approval for obtaining blood from healthy adult human volunteers was pro-
vided by the Committee for Research of the University of São Paulo (Plataforma Brasil, CAAE:
11150612500005467). All the study participants gave written informed consent.
Mice, parasites and infections
Male DBA/2 mice between 6–10 weeks old (purchased from the Department of Parasitology,
University of São Paulo, Brazil) were infected with 1x106 PbA (clone 1.49 L)-iRBCs, as previ-
ously described [18]. Parasitemia and mortality were monitored daily. Parasitemia was deter-
mined via Giemsa staining and expressed as the percentage of iRBCs. Mice were euthanized
using ketamine (150 mg/kg)/xylazine (15 mg/kg).
Determination of respiratory patterns
Respiratory patterns (respiratory frequency [RF] and enhanced pause [Penh]) were monitored
on the 7th dpi using an unrestrained whole-body plethysmography chamber (WBP, Buxco
Electronics, USA) for 10 minutes (basal level), as previously described [18].
Parasite localization via bioluminescence
DBA/2 mice were infected with PbA expressing luciferase. On the 7th dpi, mice were injected
with luciferin (VivoGlo Luciferin, In Vivo Grid, Catalog #: P1041, Promega), which result in
the parasites becoming luminescent. Parasite localization was analyzed via an IVIS Spectrum
instrument (PerkinElmer). Mice were sedated with isoflurane to take pictures (approximately
6 minutes after the injection of luciferin). Later, they were euthanized and perfused with 20 ml
of PBS 1X. After perfusion, new images of the mice were captured, and their organs were then
collected and placed in sterile petri dishes for observations of the bioluminescence of each
tissue.
Histopathological analyses
Lung tissues from the day of death were fixed with 10% buffered formalin for 24 hours and
kept in 70% ethanol until embedding in paraffin, and sections (4–5 μm) were stained with
hematoxylin-eosin (HE).
Quantification of gene expression
Quantitative RT-PCR was performed for the relative quantification of gene expression in the
lungs of non-infected and infected mice on the 7th dpi. RNA extraction was performed accord-
ing to the "Animal Cell I" protocol from the RNeasy Mini kit (Qiagen, USA). cDNA synthesis
was performed with a 1 μg RNA sample using the First Strand cDNA Synthesis RT-PCR kit
(Roche, USA) according to manufacturer’s instructions. Finally, for gene expression, SYBR
Green PCR Master Mix (Applied Biosystems, USA) and the 2(-ΔΔCT) relative quantification
method were used as described previously [58]. The qRT-PCR reactions were performed in a
7500 Fast system (Applied Biosystems, USA) with the following oligonucleotides: Ncf2 (for-
ward—5’ gcagtggcctacttccagag 3’; reverse- cttcatgttggttgccaatg) and HPRT (forward—5’
aagcttgctggtgaaaagga 3’; reverse- 5’ ttgcgctcatcttaggcttt 3’).
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Leukocyte quantification
Lungs were collected on the 7th dpi, washed with PBS 1X, and the extracellular matrix was
removed with collagenase IV (Sigma-Aldrich, USA) as previously described [59]. Lung inflam-
matory cells were stained with fluorochrome-conjugated monoclonal antibodies (BD Phar-
mingen or eBioscience, USA) to the following surface molecules: CD3 (145-2C11), CD19
(1D3), Ly6G (1A8), F4/80 (BM8), CD11c (N418), CD11b (MI/70), and Ly6C (AL-21). Cells
were then incubated for 30 min at 4˚C (1 μg Ac/1x106 cells). Data collection was performed
using a FACSCantoII cytometer (BD Bioscience, USA), and analyses were performed with
FlowJo VX-10 software. Blood leukocytes were measured using the same methods described
above and/or in fixed blood smears stained with Instant-Prov (Newprov, Brazil).
Reactive oxygen species assay
Lung inflammatory cells (1x106) from the 7th dpi were stained with antibodies for Ly6G (1A8),
CD11b (MI/70), and Ly6C (AL-21) (BD Pharmingen, USA). Intracellular levels of ROS were
detected in neutrophils using dihydrorhodamine 123 [(DHR123 - (1 μg/ml)]. Cells were incu-
bated sequentially with the antibodies and DHR123 at 37˚C for 30 minutes. Data collection
was conducted using a FACScantoII cytometer (BD Bioscience, USA) and analyzed with
FlowJo VX-10 software.
Myeloperoxidase activity
BALF and lungs were collected on the 7th dpi and sonicated for 60 seconds at 40 Hz with a Tis-
sueRuptor (Biospec Products Inc, USA), and the supernatant was collected. To measure myelo-
peroxidase levels, 100 μl of the supernatant and the substrate solution were used. The substrate
solution contained citrate buffer (10 mM citric acid + 10 mM sodium citrate), 5 mg of o-phe-
nylenediamine dihydrochloride (OPD; Sigma-Aldrich, USA) and 5 μl of H2O2 (8,8 mM). A
standard curve was established with 100 μl of type II horseradish peroxidase (Sigma-Aldrich,
USA) at 500 ng/ml + 100 μl of the substrate. The stop solution was made with 4N H2SO4. Sam-
ple reading was performed with a spectrophotometer (Epoch-Bio Tek, USA) at a wavelength
of 492 nm.
Chemokine quantification
The quantities of keratinocyte-derived chemokine (KC/CXCL1) and macrophage inflamma-
tory protein 2 (MIP-2) were determined in the serum using an ELISA kit (Sigma-Aldrich,
USA) according to the manufacturer’s protocols, on the 3rd and 5th dpi among the survival
group, for which the cause of death was known.
Bronchoalveolar lavage
For BALF collection, the trachea was cannulated on the 7th dpi, and lungs were washed once
with 1.0 ml of PBS 1X. Total and differential cell counts from the BALF were determined from
slides prepared in a cytospin and stained with Instant-Prov (Newprov, Brazil).
Neutrophil depletion assays
The control group received IgG1 antibodies (0.2 mg/mouse), and the anti-GR1 group received
anti-GR1 antibodies (RB6-8C5 isotype IgG1) (0.2 mg/mouse) on the 1st dpi. Mouse blood was
collected from the submandibular vein for leukocyte quantification using blood smears and
flow cytometry. The ALI/ARDS phenotype was confirmed via necropsies.
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AMD3100 treatment
The AMD group received 5 mg/kg of AMD3100 in a DMSO solution (20% DMSO in 80%
saline solution), and the control group received just the DMSO solution on the 1st, 3rd, 5th and
7th dpi. Respiratory parameters of the mice were evaluated on the 7th dpi. The ALI/ARDS phe-
notype was confirmed via necropsies.
Plasmodium synchronization and the enrichment of parasitized
erythrocytes
Cultures of the P. falciparum clone 3D7 were grown as described previously [60], except that
human serum was replaced with Albumax I (0.5%; Thermo, USA). Parasite multiplication was
monitored via microscopic evaluations of Giemsa-stained thick blood smears. Schizont stages
were purified using magnetic columns (Magnetically Activated Cell Sorting MACS Separation
Columns; Miltenyi Biotec, USA) [61]. Column stabilization, washing, and elution all were car-
ried out at room temperature with RPMI 1640 (Sigma-Aldrich, USA). To obtain mature PbA,
iRBCs were synchronized as described previously [60]. Briefly, iRBCs were collected from
infected mice exhibiting 10 to 20% parasitemia through a cardiac puncture and transferred to
RPMI 1640 culture medium (Gibco-Thermo, USA) supplemented with 25% fetal bovine
serum (FBS). The iRBCs were subsequently maintained in vitro at 37˚C for 14 h in an atmo-
sphere containing 5% CO2, 85% N2, and 10% O2. The parasitized erythrocytes were then
enriched using a magnetic separation column (Miltenyi Biotec, USA) to generate cell popula-
tions consisting of approximately 95% iRBCs, as assessed based on thick blood smears. P. ber-
ghei extracts were obtained from iRBCs subjected to several freeze-thaw cycles.
Isolation of polymorphonuclear cells from the bone marrow of DBA/2
mice
The femur and tibia of DBA/2 mice were removed, all muscles and tendons were dissected
away, and the bones were placed in PBS 1X with 2% FBS and kept on ice. Bone marrow from
each bone was washed with (PBS+2% FBS) and filtered through a 0.70-μm cell strainer. Cells
in suspension were centrifuged at 500 x g for 5 minutes at 4˚C, and the pellet was suspended in
ice-cold distilled water for 30 seconds to lyse the erythrocytes. Then, a solution of PBS+2%
FBS was used to stop the action of the distilled water, and the cells were centrifuged again. The
pellet was resuspended in 1 ml PBS+2% FBS and placed on the surface of a Ficoll gradient
(Sigma-Aldrich Ficoll -1119 and 1077). The samples were then centrifuged at 500 x g for 30
minutes at 4˚C (acceleration = 5 and deceleration = 0). Neutrophils were recovered from the
Ficoll ring between 1119 and 1077 and then washed with PBS+2% FBS. Finally, the neutrophils
were centrifuged again, resuspended in 1 ml PBS+2% FBS, counted, and checked for purity
based on Giemsa staining.
Ex vivo neutrophil extracellular trap (NET) generation
Human neutrophils were obtained from peripheral blood via Ficoll gradient centrifugation fol-
lowed by RBC lysis. These cells were stimulated with synchronized P. falciparum-iRBCs and
phorbol-12-myristate-13-acetate (PMA, 90 nM; Sigma-Aldrich, USA) for 4 hours at 37˚C in a
humidified atmosphere containing 5% CO2. The cells were washed with PBS 1X, fixed with 4%
paraformaldehyde (PFA; Sigma-Aldrich, USA) and then permeabilized with 1% Triton X-100
(Sigma-Aldrich, USA). Afterwards, we performed the NET labeling protocol.
Neutrophils isolated from the bone marrow of femurs and tibias from naïve DBA/2 mice
were resuspended in PBS+2% FBS at a final concentration of 2x105 cells per well. Neutrophils
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were stimulated with synchronized P. berghei-iRBCs, P. berghei lysate, non-infected red blood
cells (RBCs) and PMA (50 nM; Sigma-Aldrich, USA) for 3 hours at 37˚C in a humidified
atmosphere containing 5% CO2. The wells were washed twice with PBS 1X, fixed with PFA
(Sigma-Aldrich, USA) and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, USA).
Analysis of NETs via immunofluorescence
To stain NETs in human neutrophils, they were incubated with rabbit anti-human-neutrophil
elastase antibodies (1:1000; Santa Cruz, USA,) and mouse anti-human-H2A/H2B antibodies
(1:1000; Max Planck Institute, Germany). The secondary antibodies used were donkey anti-
rabbit-IgG Alexa 488 (1:200; Invitrogen, USA) and donkey anti-mouse-IgG Cy3 (1:100; Invi-
trogen, USA). Nuclei were stained with Hoechst 33342 (100 ng/mL; Invitrogen, USA,).
To stain NETs from DBA/2 mice, neutrophils were incubated with histone H3 goat poly-
clonal IgG (C-16) antibodies (1:200; Santa Cruz, USA) and myeloperoxidase polyclonal rabbit
anti-human antibodies (1:400; DAKO, Denmark). Nuclei were stained with Hoechst-33342
(100 ng/mL; Invitrogen, USA). The secondary antibodies used were Alexa Fluor 488 donkey
anti-rabbit and Alexa Fluor 568 donkey anti-goat (1:200; Invitrogen, USA).
To stain NETs in DBA/2 mice peripheral blood from, thin smears were made on glass slides
and fixed with methanol. Immunofluorescence staining was performed using the antibodies
described above_ anti-histone H3 (1:250), anti-myeloperoxidase (1:500), and the secondary
antibodies (1:500). Nuclei were stained with Hoechst-33342.
Lungs from mice with ALI/ARDS or HP were collected on the 7th dpi and fixed with 10%
buffered formalin for 24 hours and then transferred to 70% ethanol. Tissues were embedded in
paraffin, cut into sections (4–5 μm), and after deparaffinization, antigen retrieval and immu-
nofluorescence were assessed as described previously [62] using the same antibodies as
described from the ex vivo protocol.
Quantification of NETs using Sytox Green
To confirm the ability of the PbA to promote NETosis, Sytox Green (Invitrogen) imaging was
performed. Sytox Green is a fluorescent dye that binds to the nucleic acids of dead cells.
Approximately 5 x 105 mouse neutrophils (from the bone marrow) were distributed into
96-well black flat plates (Corning). Neutrophils were incubated with iRBCs or non-infected
RBCs for 60, 120 and 180 minutes. As a negative control, we used Hank’s buffered salt solution
(Thermo), and the positive control was established with 50 nM PMA (Sigma-Aldrich). After
incubation, the supernatant was removed, and 5 mM Sytox Green (50 mL) was added. After
10 minutes, plate readings were taken at 488–523 nm in a SpectraMAX fluorimeter (Molecular
Devices).
Mice and anti-NET drug DNase
Mice were anesthetized briefly with approximately 4% halothane and 96% oxygen and then
administered 50 μg/mouse (5 mg/kg) of DNAse 1 (Pulmozyme, Roche, USA) or a saline solu-
tion via intranasal spray on the 3rd and 6th dpi as describe previously [63]. Respiratory parame-
ters of the mice were evaluated on the 7th dpi.
Elastase inhibitor treatment
Sivelestat (Sigma-Aldrich), an elastase inhibitor, was administered to mice (30 mg/kg) diluted
in a saline solution, and the control group received just the saline solution on the 3rd and 6th
dpi. Respiratory parameters of the mice were evaluated on the 7th dpi.
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Statistical analysis
Statistical analyses and graphing were performed using GraphPad Prism 5.0 software. The
data were analyzed for normality using Kolmogorov-Smirnov or Shapiro-Wilk normality
tests, and variance was assessed using Bartlett’s test. Non-parametric variables were compared
using Mann-Whitney tests between the groups with ALI/ARDS and HP. For the analysis of
three groups, we used a Kruskal-Wallis test followed by Dunn’s post-hoc tests. For the survival
curves, log-rank and Wilcoxon-Gehan-Breslow tests were used. The differences between the
groups were considered significant at p0.05 (5%). To establish cut-off values from the data,
ROC curves were generated in MedCalc version 8.2.1.0 using the results from the infected con-
trol group (survival group).
Supporting Information
S1 Fig. The sequence of events to identify mice with ALI/ARDS before death (in a eutha-
nized group) using the parameters Penh, respiratory frequency and parasitemia as predic-
tive criteria.
(TIF)
S2 Fig. Flow cytometry analysis of pulmonary cells from non-infected and P. berghei
ANKA-infected mice (ALI/ARDS or HP) stained for reactive oxygen species with
DHR123. (A) No doublet cells gated, (B) selected cells gated by size (SSC) and granularity
(FSC), (C) Ly6G+ (neutrophils) gated cells and (D) dot plot for positive double-stained (Ly6G
and DHR123) cells.
(TIF)
S3 Fig. Monocyte and lymphocyte levels after neutrophil depletion in DBA/2 mice infected
with P. berghei ANKA. (A) Number of monocytes measured via flow cytometry and (B)
blood smears from infected control (CTR) and anti-GR1-treated mice. (C) Number of lym-
phocytes measured via flow cytometry and (D) blood smears from control (CTR) and anti-
GR1-treated mice. Data are representative of two independent experiments and are expressed
as the mean ± SEM (Kruskal-Wallis test where  p<0.05,  p <0.01 and  p<0.001; n = 10–
20 mice/experiment).
(TIF)
S4 Fig. DBA/2 mice are protected from malaria-associated ALI/ARDS by blocking the
CXCR4 receptor. Bone marrow samples from non-infected mice, mice infected with P. ber-
ghei ANKA on the day of death (9th for ALI/ARDS) and infected and treated with AMD3100
mice (21st dpi). Note that the cellularity in mice infected and then treated is considerably
higher than in infected, untreated mice (200x, scale bar 50 μm).
(TIF)
S5 Fig. Neutrophil extracellular trap (NET) structures are present in the peripheral blood
of mice infected with PbA. Smear of peripheral blood of PbA infected DBA2 mice stained for
DNA (blue), histone (red), and myleporoxidase (green). Overlapping colors indicate filamen-
tous structures (NETs). (1000x, scale bar 20 μm).
(TIF)
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